"The first study was on proguanil, a prophylactic antimalarial in healthy and sickle cell individuals. The study found that in persons with sickle cell, about one per cent of them breakdown the drug slowly while it was five per cent in healthy persons. This shows that there is genetic difference between the two groups of people."